WorldCare Clinical is the world's largest independent CRO dedicated to imaging in clinical trials. Our approach is to combine imaging expertise, innovative technology, and operational excellence to maximize the precision and accuracy of a blinded independent central review of clinical trial data. We have performed imaging services on more than 400 clinical trials.
With a 25-year heritage of providing complete imaging trial management for all modalities, we understand the needs of sponsors conducting imaging trials better than anyone.
Whether it's for a clinical trial in the pharmaceutical, biotechnology or medical device industry, WCC's highly-trained, global CRO team is dedicated to solving the most complex study designs with end-to-end imaging services and unparalleled radiology expertise. Leveraging in-house trial experts and strategic relationships with world-class, subspecialty trained board-certified physicians, we provide customized solutions that meet your project needs. From clinical operations and regulatory affairs specialists to data management experts, WCC offers an unprecedented wealth of resources to ensure an efficient and successful trial process and outcome.
To become the premier provider of blinded independent central review (BICR) of clinical trial data and a key partner with pharmaceutical, biotech and device sponsors in support of the advancement of clinical research and new drug therapies
WorldCare Clinical, LLC (WCC) was originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology. While maintaining a strategic relationship with MGH, WCC has evolved as an independent company into a leading global imaging CRO that employs imaging expertise, innovative technology and operational excellence to maximize the precision and accuracy of a blinded independent central review of clinical trial data. With a 20-year focus on imaging trials and their specific requirements, WCC provides sponsors with extensive medical, operational and image management expertise in support of even the most complex study designs.
Relationships / Industry
WCC was established as an independent company in 1995. As a valuable addition to our in-house team, we maintain a strategic relationship with the MGH Department of Radiology, which allows us to provide our sponsors with unparalleled access to world-class radiological expertise.
WCC has expanded its relationship with MGH and other Harvard Hospitals to include:
- ProScan Imaging
WCC also draws extensive global technology expertise and teleradiology capabilities from our parent company, ProScan Imaging. Each year our ProScan team collectively reads:
- 110,000 MR, 10,000 CT
- 12,000 mammogram
- 6,000 ultrasound
- 12,000 x-ray exams
The team has expertise in all facets of magnetic resonance imaging, as well as computed tomography, nuclear medicine, total-body imaging, and positron emission tomography (PET). As one of the world's most trusted and experienced radiology providers, ProScan enables us to manage virtually any volume of images for our trials and expand our global reach.